1. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies. (31st December 2020) Authors: Teichner, Paula; Wu, Sterling; Zhang, Feifan; Dorey, David; D'Amico, Ronald; Griffith, Sandy; Sutton, Kenneth; McCoig, Cynthia C; Upadhyay, Ojesh R; Polli, Joseph; Margolis, David; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William; Patel, Parul Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study. (31st December 2020) Authors: Mills, Anthony; Richmond, Gary J; Newman, Cheryl; Osiyemi, Olayemi; Cade, Jerry; Brinson, Cynthia; De Vente, Jerome; Andany, Nisha; Margolis, David; Sutton, Kenneth; Wilches, Viviana; Roberts, Jeremy; McCoig, Cynthia C; Vandermeulen, Kati; Spreen, William Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results. (31st December 2020) Authors: Smith, Graham; Henry, Keith; Podzamczer, Daniel; Masiá, Mar; Bettacchi, Christopher; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Sutton, Kenneth; Zhang, Feifan; McCoig, Cynthia C; Vandermeulen, Kati; Van Solingen-Ristea, Rodica; Spreen, William; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir. (3rd May 2020) Authors: Patel, Parul; Xue, Zhengyu; King, Karen S; Parham, Laura; Ford, Susan; Lou, Yu; Bakshi, Kalpana K; Sutton, Kenneth; Margolis, David; Hughes, Arlene R; Spreen, William R Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 8(2020) Page Start: 2240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LB-8. Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials. (31st December 2020) Authors: D'Amico, Ronald; Benn, Paul; McCoig, Cynthia C; McCoig, Cynthia C; Griffith, Sandy; Hudson, Krischan J; Sutton, Kenneth; Sutton, Kenneth; Harrington, Conn M; Wu, Sterling; Williams, Will; Hove, Kai S; Martin Espanol, Carlos; Fricker, E Jane; Patel, Parul; Margolis, David; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults. (24th December 2019) Authors: Letendre, Scott L; Mills, Anthony; Hagins, Debbie; Swindells, Susan; Felizarta, Franco; Devente, Jerome; Bettacchi, Christopher; Lou, Yu; Ford, Susan; Sutton, Kenneth; Shaik, Jafar Sadik; Crauwels, Herta; D'Amico, Ronald; Patel, Parul Journal: Journal of antimicrobial chemotherapy Issue: Volume 75:Number 3(2020) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗